Provided by Tiger Fintech (Singapore) Pte. Ltd.

BOTANIX PHARMACEUTICALS LTD

0.140
-0.010-6.67%
Volume:9.36M
Turnover:1.36M
Market Cap:274.56M
PE:-6.02
High:0.150
Open:0.150
Low:0.140
Close:0.150
Loading ...

Company Profile

Company Name:
BOTANIX PHARMACEUTICALS LTD
Exchange:
ASX
Establishment Date:
1984
Employees:
11
Office Location:
41 – 47 Colin Street,Suite 3,West Perth,Western Australia,Australia
Zip Code:
6005
Fax:
61 8 6210 1153
Introduction:
Botanix Pharmaceuticals Limited, a clinical stage cannabinoid therapeutics company, develops therapeutics for serious skin diseases in Australia. It offers BTX 1503, a transdermal gel formulation for the treatment of serious acne in adults and teenagers; BTX 1308, a transdermal gel formulation for the treatment of plaque psoriasis; BTX 1204, a transdermal gel formation for the treatment of atopic dermatitis; BTX 1701, a novel product for mild acne; and BTX 1801, a novel antimicrobial. The company is based in North Perth, Australia.